Medizinische Klinik III, Nephrologie und Dialyse, St. Vincenz-Krankenhaus Paderborn, Am Busdorf 2, 33098, Paderborn, Germany.
Medizinische Klinik I, Nephrologie, Transplantation und Internistische Intensivmedizin, Krankenhaus Merheim, Kliniken der Stadt Köln, Klinikum der Universität Witten/Herdecke, Köln, Germany.
BMC Nephrol. 2021 Jul 6;22(1):251. doi: 10.1186/s12882-021-02448-1.
The ongoing coronavirus pandemic has major impacts on both patients and healthcare systems worldwide, thus creating new realities. Patients on maintenance dialysis listed for renal transplantation are a vulnerable subgroup with many comorbidities and recurring contacts with the healthcare system. Due to the COVID-19 pandemic transplant numbers have dropped considerably, further increasing waiting times in this high-risk population. On the other hand, knowledge of the severity of SARS-CoV-2 infection in immunocompromised patients, development and persistence of neutralising antibodies in such patients is just emerging. It is unclear how best to address the dilemma of postponing the life-saving transplantation.
We present a case report of a successful kidney transplantation only 65 days after the recipient was hospitalized for treatment of COVID-19 pneumonia. In a follow up of 9 months, we observed no signs of recurrent disease and transplant function is excellent. Monitoring SARS-CoV-2 antibody response demonstrates stable IgG levels.
This reassuring case provides guidance to transplant centers how to proceed with kidney transplantation safely during the pandemic. Careful consideration of risks and benefits of the organ offer, full recovery from COVID-19 symptoms and the presence of a positive SARS-CoV-2 IgG antibody test, qualifies for kidney transplantation.
持续的冠状病毒大流行对全球的患者和医疗体系都产生了重大影响,从而创造了新的现实。维持性透析并等待肾移植的患者是一个脆弱的亚组,他们有许多合并症,并经常与医疗体系接触。由于 COVID-19 大流行,移植数量大幅下降,这进一步增加了高危人群的等待时间。另一方面,人们对免疫功能低下患者中 SARS-CoV-2 感染的严重程度、此类患者中中和抗体的产生和持续存在的认识才刚刚开始。尚不清楚如何最好地解决推迟挽救生命的移植的困境。
我们报告了一例成功的肾移植病例,在接受 COVID-19 肺炎治疗住院仅 65 天后,受者接受了肾移植。在 9 个月的随访中,我们没有观察到疾病复发的迹象,移植功能良好。监测 SARS-CoV-2 抗体反应显示 IgG 水平稳定。
这个令人安心的病例为移植中心在大流行期间如何安全地进行肾移植提供了指导。仔细考虑器官供体的风险和收益、COVID-19 症状的完全康复以及 SARS-CoV-2 IgG 抗体检测呈阳性,这些都符合肾移植的条件。